Latest period
544.00M
YoY change
+0.2%
5Y CAGR
-1.7%
Peak year (2003)
1.35B
Latest annual
542.00M
Shares Outstanding history chart for Amgen (AMGN) from 1985 to 2025
Latest: 542.00M
Shares Outstanding growth chart for Amgen (AMGN) from 1985 to 2025
Latest: +0.2%
Shares Outstanding history table for Amgen (AMGN) from 1985 to 2025
| 2025 | 542.00M | +0.2% | +1.00M | ||
| 2024 | 541.00M | +0.6% | +3.00M | ||
| 2023 | 538.00M | -0.6% | -3.00M | ||
| 2022 | 541.00M | -5.6% | -32.00M | ||
| 2021 | 573.00M | -2.9% | -17.00M | ||
| 2020 | 590.00M | -3.1% | -19.00M | ||
| 2019 | 609.00M | -8.4% | -56.00M | ||
| 2018 | 665.00M | -9.5% | -70.00M | ||
| 2017 | 735.00M | -2.5% | -19.00M | ||
| 2016 | 754.00M | -1.6% | -12.00M | ||
| 2015 | 766.00M | -0.5% | -4.00M | ||
| 2014 | 770.00M | +0.7% | +5.00M | ||
| 2013 | 765.00M | -2.8% | -22.00M | ||
| 2012 | 787.00M | -13.7% | -125.00M | ||
| 2011 | 912.00M | -5.5% | -53.00M | ||
| 2010 | 965.00M | -5.5% | -56.00M | ||
| 2009 | 1.02B | -5.0% | -54.00M | ||
| 2008 | 1.07B | -4.3% | -48.00M | ||
| 2007 | 1.12B | -5.6% | -67.00M | ||
| 2006 | 1.19B | -5.4% | -68.00M | ||
| 2005 | 1.26B | -4.7% | -62.00M | ||
| 2004 | 1.32B | -1.9% | -26.00M | ||
| 2003 | 1.35B | +16.7% | +192.50M | ||
| 2002 | 1.15B | +6.4% | +69.10M | ||
| 2001 | 1.08B | -0.0% | -300,000 | ||
| 2000 | 1.08B | +0.6% | +6.40M | ||
| 1999 | 1.08B | +2.0% | +20.90M | ||
| 1998 | 1.06B | -3.7% | -41.00M | ||
| 1997 | 1.10B | -2.2% | -25.20M | ||
| 1996 | 1.12B | -1.5% | -17.60M | ||
| 1995 | 1.14B | +1.1% | +12.41M | ||
| 1994 | 1.13B | +3.1% | +33.65M | ||
| 1993 | 1.10B | -5.1% | -58.41M | ||
| 1992 | 1.15B | +6.0% | +65.77M | ||
| 1991 | 1.09B | +70.9% | +451.11M | ||
| 1990 | 636.67M | — | — | ||
| 1988 | 820.00M | -12.8% | -120.86M | ||
| 1987 | 940.86M | 0.0% | 0 | ||
| 1986 | 940.86M | +62.0% | +359.96M | ||
| 1985 | 580.90M | — | — |
- 2025542.00M+0.2%
- 2024541.00M+0.6%
- 2023538.00M-0.6%
- 2022541.00M-5.6%
- 2021573.00M-2.9%
- 2020590.00M-3.1%
- 2019609.00M-8.4%
- 2018665.00M-9.5%
- 2017735.00M-2.5%
- 2016754.00M-1.6%
- 2015766.00M-0.5%
- 2014770.00M+0.7%
- 2013765.00M-2.8%
- 2012787.00M-13.7%
- 2011912.00M-5.5%
- 2010965.00M-5.5%
- 20091.02B-5.0%
- 20081.07B-4.3%
- 20071.12B-5.6%
- 20061.19B-5.4%
- 20051.26B-4.7%
- 20041.32B-1.9%
- 20031.35B+16.7%
- 20021.15B+6.4%
- 20011.08B-0.0%
- 20001.08B+0.6%
- 19991.08B+2.0%
- 19981.06B-3.7%
- 19971.10B-2.2%
- 19961.12B-1.5%
- 19951.14B+1.1%
- 19941.13B+3.1%
- 19931.10B-5.1%
- 19921.15B+6.0%
- 19911.09B+70.9%
- 1990636.67M—
- 1988820.00M-12.8%
- 1987940.86M0.0%
- 1986940.86M+62.0%
- 1985580.90M—
Shares Outstanding values are taken from Amgen's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Shares Outstanding at Amgen (AMGN)
According to Amgen's latest reported financial statements, the company's latest reported diluted shares outstanding is 544.00M. Diluted weighted-average shares outstanding is the share count used to compute per-share metrics like EPS. Buybacks lower it; new issuance, stock-based compensation, and convertible securities raise it. Multiply by the stock price for market capitalization.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
Amgen (AMGN) most recent annual diluted shares outstanding stands at 542.00M (2025) – edged up 0.2% year-over-year.
Looking at the 2020–2025 (5 years) stretch, Amgen diluted shares outstanding compounded at -1.7% per year, sustaining 2 straight years of year-over-year growth.
Between 2003 and 2025, Amgen diluted shares outstanding plunged 59.7%, falling from 1.35B to 542.00M.
Across the available history, diluted shares outstanding reached its high of 1.35B in 2003 and its low of 538.00M in 2023.
Amgen Shares Outstanding by Year
Amgen Shares Outstanding 2025: 542.00M
Amgen posted diluted shares outstanding of 542.00M in 2025, edged up 0.2% from 2024.
Amgen Shares Outstanding 2024: 541.00M
In 2024, Amgen reported diluted shares outstanding of 541.00M, edged up 0.6% from 2023.
Amgen Shares Outstanding 2023: 538.00M
Amgen diluted shares outstanding in 2023 was 538.00M, edged down 0.6% below 2022. This figure represents the lowest annual value in the available history.
Amgen Shares Outstanding 2022: 541.00M
2022's diluted shares outstanding for Amgen came in at 541.00M, declined 5.6% below 2021.
Amgen Shares Outstanding 2021: 573.00M
Amgen diluted shares outstanding in 2021 was 573.00M.
See more financial history for Amgen (AMGN).
Sector peers by Shares Outstanding
Healthcare peers of Amgen (AMGN), ranked by their latest diluted shares outstanding
| 4.45B | |
| 2.51B | |
| 2.43B | |
| 1.77B | |
| 1.56B | |
| 910.00M | |
| 898.00M | |
| 377.00M |
- 4.45B
- 2.51B
- 1.77B
- 1.56B
- 910.00M
- 898.00M
Frequently asked questions
Amgen (AMGN) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation